Subcellular pharmacology of natriuretic and potassium-sparing drugs.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000450:Aldosterone / Q000494:pharmacology; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002301:Cardiac Glycosides / Q000494:pharmacology; D002740:Chlorothiazide / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004976:Ethacrynic Acid / Q000494:pharmacology; D006019:Glycolysis; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008566:Membranes / Q000201:enzymology / Q000378:metabolism; D009318:Natriuresis / Q000187:drug effects; D009399:Nephrons; D011188:Potassium / Q000378:metabolism* / Q000652:urine; D012964:Sodium / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013347:Subcellular Fractions
D002301:Cardiac Glycosides; D004232:Diuretics; D000450:Aldosterone; D002740:Chlorothiazide; D000584:Amiloride; D012964:Sodium; D000251:Adenosine Triphosphatases; D004976:Ethacrynic Acid; D011188:Potassium